Dr Luis Alameda is Senior Clinical Lecturer in the Department of Psychosis Studies at the Institute of Psychiatry Psychology and Neuroscience at King's College London. He is also a Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust.

Dr Luis Alameda studied at Universities of Sevilla, Lund and Florence and he trained in psychiatry and psychotherapy in Lausanne University Hospital. From 2017 to 2022 he worked in South London and Maudsley as a Consultant psychiatrist while he coursed a PhD at the Department of Psychosis Studies. His PhD was on child abuse and epigenetics and psychological mechanisms in first episode psychosis.

Between  2022 and 2024  Dr Alameda led the Treatment and Early Intervention in Psychosis Program (TIPP) in Lausanne while he conducted a postdoc focusing on clinical high risk for psychosis populations, and data driven developments.

He came back to the Department as a Senior Clinical Lecturer in psychosis and as a Consultant Psychiatrist at the National Psychosis Unit. Dr Alameda's PhD was awarded the Kings Outstanding Kings Prize and the Psychosis Studies PhD of the year both in 2022.

Luis has also been awarded the 2019 Research Prize for by the European Psychiatric Association, and the Young Investigator Award from the Swiss Society of Biological psychiatry and the Spanish Society of Psychiatry and Mental Health.

His research focuses on the understanding of the mechanism involved in psychosis in people with trauma, and how this impact poor outcome. He is also interested in service developments, specially in the area of early intervention in Psychosis. 

Key Publications

• Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
• Can epigenetics shine a light on the biological pathways underlying major mental disorders?
• Association Between Specific Childhood Adversities and Symptom Dimensions in People With Psychosis: Systematic Review and Meta-Analysis
• A systematic review on mediators between adversity and psychosis: potential targets for treatment
• Redox dysregulation as a link between childhood trauma and psychopathological and neurocognitive profile in patients with early psychosis